Nifty Pharma Jumps 3.7% as 108 of 130 Stocks Advance
MarketPulse Summary: Nifty Pharma gained 3.7% (937.85 points) to 26,267.25, with 108 of 130 stocks advancing against 21 declining. Smaller stocks averaged 2.6%, slightly ahead of the top 10 companies at 2.22%, indicating balanced participation.
📊 Key Numbers
📈 Sector Performance
| Metric | Value |
|---|---|
| Index Level | 26,267.25 |
| Previous Close | 25,329.40 |
| Change | +3.70% |
| Change Points | 937.85 |
🎯 What drove the move?
Market reports provided contextual factors around the sector move, but the available evidence does not establish a single confirmed catalyst.
📊 Market Breadth
Across the broader Pharma stock universe used in this analysis, 21 of 130 stocks declined, while 108 advanced and 1 remained unchanged. Decliners represented 16.15%, compared with 83.08% for advancers. The breadth score was 66.92, indicating strongly positive internal conditions. This universe should not be treated as the official index constituent universe unless separately verified.
| Category | Stocks | Share |
|---|---|---|
| Advancing | 108 | 83.08% |
| Declining | 21 | 16.15% |
| Unchanged | 1 | — |
| Breadth Score | 66.92 | |
🏢 Large Caps vs Smaller Stocks
The top 10 companies by market capitalization averaged 2.22%, while smaller stocks averaged 2.60%. The market-cap-weighted change was 2.37%, compared with a median change of 2.20% and a simple average of 2.57%. The leadership condition was balanced. The divergence indicates that the magnitude of the sector move was concentrated in larger companies.
🚀 Top Gainers
| Stock | LTP | % |
|---|---|---|
|
ONESOURCE
Onesource Specialty Pharma Limited
|
₹1,589.80 | +13.78% |
|
ACUTAAS
Acutaas Chemicals Limited
|
₹3,793.30 | +13.27% |
|
INDSWFTLAB
Ind-Swift Laboratories Limited
|
₹368.80 | +9.42% |
|
PGHL
Procter & Gamble Health Limited
|
₹5,489.00 | +8.56% |
|
ERIS
Eris Lifesciences Limited
|
₹1,198.40 | +8.43% |
📉 Top Losers
| Stock | LTP | % |
|---|---|---|
|
AMANTA
Amanta Healthcare Limited
|
₹157.74 | -5.46% |
|
FISCHER
Fischer Medical Ventures Limited
|
₹25.54 | -5.41% |
|
VENUSREM
Venus Remedies Limited
|
₹1,388.80 | -4.99% |
|
SAKAR
Sakar Healthcare Limited
|
₹930.30 | -4.17% |
|
KREBSBIO
Krebs Biochemicals and Industries Limited
|
₹59.64 | -4.15% |
🏦 Largest Companies
Among the top gainers, Onesource Specialty Pharma Limited gained 13.78% to 1,589.80, Acutaas Chemicals Limited gained 13.27% to 3,793.30, Ind-Swift Laboratories Limited gained 9.42% to 368.80. On the losing side, Amanta Healthcare Limited fell 5.46% to 157.74, Fischer Medical Ventures Limited fell 5.41% to 25.54, Venus Remedies Limited fell 4.99% to 1,388.80. Among the largest companies, Sun Pharmaceutical Industries Limited gained 0.64%, Divi's Laboratories Limited gained 5.03%, Torrent Pharmaceuticals Limited gained 1.65%, Zydus Lifesciences Limited gained 1.08%, Cipla Limited declined 0.37%. The available research does not establish specific reasons for individual stock moves.
| Stock | Market Cap | LTP | % |
|---|---|---|---|
|
SUNPHARMA
Sun Pharmaceutical Industries Limited
|
4,60,672cr | ₹1,751.20 | +0.64% |
|
DIVISLAB
Divi's Laboratories Limited
|
2,45,266cr | ₹9,505.50 | +5.03% |
|
TORNTPHARM
Torrent Pharmaceuticals Limited
|
1,92,086cr | ₹4,625.00 | +1.65% |
|
ZYDUSLIFE
Zydus Lifesciences Limited
|
1,18,803cr | ₹1,172.90 | +1.08% |
|
CIPLA
Cipla Limited
|
1,14,999cr | ₹1,350.00 | -0.37% |
|
LAURUSLABS
Laurus Labs Limited
|
1,04,740cr | ₹2,142.00 | +4.04% |
|
LUPIN
Lupin Limited
|
99,295cr | ₹1,952.00 | -0.40% |
|
MANKIND
Mankind Pharma Limited
|
98,413cr | ₹2,502.50 | +8.24% |
|
DRREDDY
Dr. Reddy's Laboratories Limited
|
98,325cr | ₹1,310.00 | -0.07% |
|
AUROPHARMA
Aurobindo Pharma Limited
|
94,667cr | ₹1,627.50 | +2.36% |
📝 What the data suggests
Broad-Based Pharma Strength
The data shows strongly positive internal sector conditions. The relationship between breadth, large-cap performance and smaller-stock performance should be considered when interpreting the move.
👀 What to watch next
The divergence between large-cap and smaller stocks remains relevant to the sector's internal structure. The broad-based pharma strength remains the key data-supported theme.
📊 Track Live Markets
Real-time Nifty data, sector performance, market breadth, stock movers and AI-powered analysis.
Open Dashboard →Data generated at 27 Oct 2026. Not investment advice.